EcoDrugPlus

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSBMUG00000026836
Gene Symbol: AVPR1B
3 Cross references
135 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSBMUG00000012644
Gene Symbol: AVPR2
3 Cross references
251 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSBMUG00000017457
Gene Symbol: AHR
3 Cross references
155 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSBMUG00000016455
Gene Symbol: AURKA
3 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSBMUG00000022379
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSBMUG00000026339
Gene Symbol: AURKC
2 Cross references
91 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSBMUG00000013418
Gene Symbol: BACE1
3 Cross references
220 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSBMUG00000002286
Gene Symbol: BDKRB2
3 Cross references
362 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSBMUG00000014130
Gene Symbol: BCHE
3 Cross references
130 Possible Orthologues:

Cgmp-Inhibited 3',5'-Cyclic Phosphodiesterase B

Ensembl ID : ENSBMUG00000022069
Gene Symbol: LOC102285991
2 Cross references
204 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSBMUG00000022938
Gene Symbol: CALCRL
3 Cross references
149 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSBMUG00000014466
Gene Symbol: CASR
3 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).